Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001102624-15-000441
Filing Date
2015-03-27
Accepted
2015-03-27 13:06:05
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-K boston10k.htm 10-K 1676923
2 EXHIBIT 23.1 exh23_1.htm EX-23.1 2804
3 EXHIBIT 31.1 exh31_1.htm EX-31.1 17537
4 EXHIBIT 31.2 exh31_2.htm EX-31.2 17732
5 EXHIBIT 32.1 exh32_1.htm EX-32.1 8240
6 EXHIBIT 32.2 exh32_2.htm EX-32.2 7990
  Complete submission text file 0001102624-15-000441.txt   5052217

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bthe-20141231.xml EX-101.INS 490247
8 XBRL TAXONOMY EXTENSION SCHEMA bthe-20141231.xsd EX-101.SCH 34000
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bthe-20141231_cal.xml EX-101.CAL 37659
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bthe-20141231_def.xml EX-101.DEF 66698
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bthe-20141231_lab.xml EX-101.LAB 248735
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bthe-20141231_pre.xml EX-101.PRE 181912
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 15730045
SIC: 2834 Pharmaceutical Preparations